Podcast

Rakesh Gopinathannair, MD, on Left Ventricular Assist Devices

07/02/2019

 

Rakesh Gopinathannair, MD, MA, talks about left ventricular assist devices, as well as how to identify and manage the challenges associated with arrhythmias.

Additional Resources:

  1. Gopinathannair R, Cornwell WK, Dukes JW, et al. Device therapy and arrhythmia management in left ventricular assist device recipients: a scientific statement from the American Heart Association [published online May 14, 2019]. Circulation. doi:10.1161/CIR.0000000000000673.
  2. Clerkin KJ, Topkara VK, Demmer RT, et al. Implantable cardioverter-defibrillators in patients with a continuous-flow left ventricular assist device: an analysis of the INTERMACS registry. JACC Heart Fail. 2017;5(12):916-926. doi:10.1016/j.jchf.2017.08.014.
  3. Gopinathannair R, Roukoz H, Trivedi JR, et al. Impact of QRS duration and ventricular pacing on clinical and arrhythmic outcomes in continuous flow left ventricular assist device recipients: a multicenter study [published online February 21, 2019]. J Card Fail. doi:10.1016/j.cardfail.2019.02.013. 
  4. Gopinathannair R, Roukoz H, Bhan A, et al. Cardiac resynchronization therapy and clinical outcomes in continuous flow left ventricular assist device recipients [published online June 19, 2018]. J Am Heart Assoc. doi:10.1161/JAHA.118.009091.
  5. Richardson TD, Hale L, Arteaga C, et al. Prospective randomized evaluation of implantable cardioverter-defibrillator programming in patients with a left ventricular assist device [published online February 23, 2018]. J Am Heart Assoc. doi:10.1161/JAHA.117.007748.
  6. Hottigoudar RU, Deam AG, Birks EJ, McCants KC, Slaughter MS, Gopinathannair R. Catheter ablation of atrial flutter in patients with left ventricular assist device improves symptoms of right heart failure. Congest Heart Fail. 2013;19(4):165-171. doi:10.1111/chf.12034.
  7. Sacher F, Reichlin T, Zado ES, et al. Characteristics of ventricular tachycardia ablation in patients with continuous flow left ventricular assist devices. Circ Arrhythm Electrophysiol. 2015;8(3):592-597. https://doi.org/10.1161/CIRCEP.114.002394. 

 

Rakesh Gopinathannair, MD, MA, FAHA, FACC, FHRS, is the director of the Cardiac EP Lab at the Kansas City Heart Rhythm Institute; professor of medicine at the University of Missouri-Columbia; associate professor of medicine (adjunct) at the University of Louisville; and chair of the Communications Committee at the Heart Rhythm Society. You can reach him at rakesh.gopinathannair@hcahealthcare.com or drrakeshg@yahoo.com.

Related Content

Cardiology
Cardiology
Roxana Mehran, MD, on Optimal DAPT Therapies
02/21/2020
She talks about new dual-antiplatelet therapy (DAPT) regimens and lessons learned about new DAPT from recent research.
02/21/2020
HIV Infection
HIV Infection
Vicente Planelles, PhD, on Gender Influences of SAMHD1 Activity
07/12/2019
He discusses his recently published research on how sex influences SAMHD1 activity and susceptibility to HIV-1.
07/12/2019
Neurology
Neurology
Bardia Nourbakhsh, MD, on Diagnosis Tools for Multiple Sclerosis
07/23/2018
Bardia Nourbakhsh, MD, from Johns Hopkins University School of Medicine discusses the different diagnosis tools for multiple sclerosis, as well as challenges in diagnosis.
07/23/2018
Menopause
Menopause
The Vaginal Microbiome After Menopause
05/19/2022
Caroline Mitchell, MD, reviews the link between the vaginal microbiome and reproductive health, the shift in the vaginal microbial community’s composition after menopause, and more.
05/19/2022
Digestive Disorders
Digestive Disorders
Alessio Fasano, MD, on the Importance of Novel Tools to Better Understand Celiac Disease
08/08/2019
Alessio Fasano, MD, discusses the need for more novel tools to perform better research on celiac disease, his research on a new 3-dimensional model for studying the effect of microbiota-derived...
08/08/2019